fitEmaxB.Set the parameters of the prior distribution for the Emax model implemented in fitEmaxB..
emaxPrior.control(epmu=NULL,epsca=NULL,
difTargetmu=NULL,difTargetsca=NULL,
dTarget=NULL,p50=NULL,
sigmalow=NULL,sigmaup=NULL,
effDF=parmDF,parmDF=5,
loged50mu=0.0,loged50sca=1.73,
loglammu=0.0,loglamsca=0.425,parmCor=-0.45,
lowled50=log(0.001),highled50=log(1000),
lowllam=log(0.3),highllam=log(4.0),
basemu=NULL,basevar=NULL,binary=FALSE)List of class emaxPrior of prior parameter values for use in
fitEmaxB. default is a derived variable set to
TRUE when the default values are used for loged50
and loglambda.
Mean for E0 in a t-prior distribution. Logistic scale for binary data.
The scale parameter for E0 in a t-prior distribution. Logistic scale for binary data.
Mean for the prior distribution of the effect at dose dTarget versus placebo.
Logistic scale for binary data.
The scale parameter for the prior distribution of the effect at dose dTarget versus placebo.
Logistic scale for binary data.
Target dose for prior effect. Typically the highest dose planned and/or the proof-of-concept dose.
Projected ED50. See references for its use in creating the prior distribution for the ED50.
Lower bound for a uniform prior distribution for the residual SD (continuous data).
Upper bound for a uniform prior distribution for the residual SD (continuous data).
The degrees of freedom for the prior distributions for the placebo
and difTarget parameters. If a vector of length 2 is specified, the first value is the
degrees of freedom for placebo and the second for difTarget.
The degrees of freedom of the bivariate log-t prior distribution for the ED50 and lambda parameters.
Mean of prior t-distribution for the log(ED50/P50). See references for
its default value and interpretation.
Scale (analogous to SD) of the prior t-distribution for the log(ED50/P50).
Mean of prior t-distribution for the Hill parameter lambda. See references for its default value and interpretation.
Scale (analogous to SD) of the prior t-distribution for the Hill parameter lambda.
Correlation for the bivariate log-t prior distribution for the ED50 and lambda parameters.
Bounds applied to the prior distributions for the log(ED50/P50) and log(lambda). The original (unbounded) priors are modified to be conditional on being within the bounds. This is done for numerical stability and plausibility of the parameter values
A vector of prior means for the covariate regression parameters.
The prior variance-covariance matrix for the covariate regression parameters. The covariate regression parameters are a priori independent of the other dose response model parameters.
Set to TRUE for binary data applications. Used to check for consistency in usage. The default is FALSE
Neal Thomas
The prior distribution is based on meta-analyses of dose response described in the references. The E0 and difTarget parameters have independent t-distribution prior distributions. For binary data, these parameters are computed on the logistic scale. The prior means and scales of these parameters must be assigned compound-specific values. The predicted ED50 at the study design stage must must also be specified as 'P50'. For continuous data, the prior distribution for the residual SD is uniform on a user-specifed scale.
The prior distribution of the log(ED50) has a t-distribution
centered at log(P50), with scale, degrees of freedom (parmDF),
and offset to the P50,
defaulting to values given in the references (these can be changed, but they
are difficult to interpret outside the context of the meta-analyses).
If modType=4, the prior distribution for the Hill parameter
is also t-distribution with parmDF degrees of freedom and corParm
correlation with the log(ED50).
Thomas, N., Sweeney, K., and Somayaji, V. (2014). Meta-analysis of clinical dose response in a large drug development portfolio, Statistics in Biopharmaceutical Research, Vol. 6, No.4, 302-317. <doi:10.1080/19466315.2014.924876>
Thomas, N., and Roy, D. (2016). Analysis of clinical dose-response in small-molecule drug development: 2009-2014. Statistics in Biopharmaceutical Research, Vol. 6, No.4, 302-317 <doi:10.1080/19466315.2016.1256229>
Wu, J., Banerjee, A., Jin, B., Menon, S., Martin, S., and Heatherington, A. (2017). Clinical dose-response for a broad set of biological products: A model-based meta-analysis. Vol. 9, 2694-2721. <doi:10.1177/0962280216684528?>
fitEmaxB